Phytochemical Name : Myricetin

Properties Information
PhytoCAT-ID PhytoCAT-1876
Phytochemical name or plant extracts Myricetin
PMID 27249025
Literature evidence The use of small molecules to arrest G-quadruplex structure has become a potential strategy for the development and design of a new class of anticancer therapeutics.
IUPAC name 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
Phytochemicals’ class or type of plant extracts Polyphenol Flavonoid
Source of phytochemicals or plant Extracts Withania coagulans
Geographical availability Afghanistan, India, Iran, Nepal, Oman, Pakistan
Plant parts Leaves
Other cancers Breast cancer
Target gene or protein p53, BRCA1, GADD45, Bax, Bcl-2
Gene or Protein evidence The expression rate of apoptotic genes caspase-3, caspase-8, caspase-9, the ratio of BAX /Bcl-2 as well as the expression of P53, BRCA1, GADD45 genes were increased significantly after treatment of T47D breast cancer cells with myricetin.
Target pathways Myricetin Exerts its Apoptotic Effects on MCF-7 Breast Cancer Cells through Evoking the BRCA1-GADD45 Pathway. Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways. Myricetin suppresses p21-activated kinase 1 in human breast cancer MCF-7 cells through downstream signaling of the β-catenin pathway. Myricetin enhances apoptosis in T47D breast cancer cells by evoking both extrinsic and intrinsic apoptotic pathways. myricetin may practices its apoptotic properties on T47D cells through inducing BRCA1- GADD45 pathway.
IC50 14.75 μM against MDA-MB-231
Potency NA
Cell line/ mice model MCF-7, T47D, MDA-MB-231
Additional information  Myricetin also induced hydrogen peroxide (H2O2) production in cell-free culture medium, as well as in the presence of TNBC cells and normal cells.
PubChem ID 5281672
Additional PMIDs 33369440 31266091 29742465 27122002 33369470 29579978 29984179
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:821678-1
Safety NA